Overly broad-spectrum antibiotic treatment of wild-type <i>Pseudomonas aeruginosa</i> infections in relation to the EUCAST new definition of susceptibility testing categories, a retrospective multicentre cohort study

Ourghanlian, Clément; Fihman, Vincent; Morel, Antoine; Lafont, Charlotte; Galy, Adrien; Calimouttoupoulle, Eimma; Woerther, Paul‐Louis; Lepeule, R.

doi:10.1093/jacamr/dlac099

Public

Overly broad-spectrum antibiotic treatment of wild-type Pseudomonas aeruginosa infections in relation to the EUCAST new definition of susceptibility testing categories, a retrospective multicentre cohort study

Published in JAC-Antimicrobial Resistance • Sep 5, 2022

Authors:

Clément Ourghanlian

Vincent Fihman

Antoine Morel

Abstract

Abstract Objectives EUCAST changed the definition of the ‘intermediate’ (I) category in 2019, now defined as ‘susceptible, increased exposure’. This new definition could lead to an increased prescription of antibiotics still reported as ‘S’, compared with those now reported as ‘I’. The objective of ...

Subject

Meropenem

Antibiotics

Antimicrobial stewardship

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!